Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials

Journal:

European Heart Journal

Published:

2026-05-25

DOI:

10.1093/eurheartj/ehag399

Affiliations:

6

Authors:

9

Go to article

Institutions	Authors	Share
NewAmsterdam Pharma B.V., Netherlands	4.500000	0.50
Monash University, Australia	2.000000	0.22
Imperial College London (ICL), United Kingdom (UK)	1.000000	0.11
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	0.500000	0.06
SUNY Downstate Health Sciences University (SUNY Downstate), United States of America (USA)	0.500000	0.06
University of Amsterdam (UvA), Netherlands	0.500000	0.06

Interested in Cardiovascular Medicine and Haematology?